1. Home
  2. INVE vs APLT Comparison

INVE vs APLT Comparison

Compare INVE & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • APLT
  • Stock Information
  • Founded
  • INVE 1990
  • APLT 2016
  • Country
  • INVE United States
  • APLT United States
  • Employees
  • INVE N/A
  • APLT N/A
  • Industry
  • INVE Computer peripheral equipment
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • APLT Health Care
  • Exchange
  • INVE Nasdaq
  • APLT Nasdaq
  • Market Cap
  • INVE 86.5M
  • APLT 80.3M
  • IPO Year
  • INVE 1997
  • APLT 2019
  • Fundamental
  • Price
  • INVE $3.51
  • APLT $0.65
  • Analyst Decision
  • INVE Strong Buy
  • APLT Buy
  • Analyst Count
  • INVE 2
  • APLT 7
  • Target Price
  • INVE $7.25
  • APLT $6.10
  • AVG Volume (30 Days)
  • INVE 32.5K
  • APLT 3.5M
  • Earning Date
  • INVE 03-11-2025
  • APLT 03-05-2025
  • Dividend Yield
  • INVE N/A
  • APLT N/A
  • EPS Growth
  • INVE N/A
  • APLT N/A
  • EPS
  • INVE 3.10
  • APLT N/A
  • Revenue
  • INVE $104,217,000.00
  • APLT N/A
  • Revenue This Year
  • INVE N/A
  • APLT N/A
  • Revenue Next Year
  • INVE N/A
  • APLT $2,622.90
  • P/E Ratio
  • INVE $1.16
  • APLT N/A
  • Revenue Growth
  • INVE 70.57
  • APLT N/A
  • 52 Week Low
  • INVE $2.95
  • APLT $0.54
  • 52 Week High
  • INVE $9.24
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • INVE 44.12
  • APLT 35.67
  • Support Level
  • INVE $3.41
  • APLT $0.54
  • Resistance Level
  • INVE $3.67
  • APLT $0.66
  • Average True Range (ATR)
  • INVE 0.19
  • APLT 0.06
  • MACD
  • INVE 0.01
  • APLT 0.09
  • Stochastic Oscillator
  • INVE 27.91
  • APLT 81.26

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: